CRDN

Views & Analysis

The lessons that can be learned for the future of drug development from the collaboration and innovation in this space.

Views & Analysis

CRDN wants to break down barriers in communication between rare disease patients, HCPs and industry.

News

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.